The Hottest Startup On The Market Plants Trees While You Commute
FN Media Group Presents Oilprice.com Market Commentary London – March 26, 2020 – We’ve come a long way in a short time since ride-sharing emerged as a mainstream offering. Now, there’s even an app that lets consumers participate in one of the biggest trends of the decade without leaving an environmental footprint. It’s the app […]
WHO Officials Indicating At Least 20 Vaccines In Development In Global Race For A Cure
Palm Beach, FL – March 25, 2020 – The World Health Organization is working with scientists across the globe on at least 20 different coronavirus vaccines with some already in clinical trials in record time — just 60 days after sequencing the gene, according to reports from CNBC. “The acceleration of this process is really truly […]
BioSig subsidiary NeuroClear acquires license for a broad-spectrum anti-viral agent that may treat COVID-19. Laboratory results demonstrate high level of activity against COVID-19 in cell culture
Novel pharmaceutical Vicromax(tm)* has already undergone extensive animal testing and human clinical experience in other indications Westport, CT – March 25, 2020 – BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform, today announced that its majority-owned subsidiary NeuroClear Technologies, Inc. acquired the rights […]
Cesium – The Most Important Metal You’ve Never Heard Of
FN Media Group Presents Oilprice.com Market Commentary London – March 25, 2020 – The 5G revolution, American military defense, and even time itself are dependent on this one critical metal that China monopolizes and that the U.S. is desperate to get more of. Mentioned in today’s commentary includes: Turquoise Hill Resources Ltd. (NYSE: TRQ), […]
WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications
Testing of drug candidate WP1122 to be done by leading Government funded research institution specializing in infectious diseases including COVID-19 Vancouver, BC – March 24, 2020 – WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, announces it has entered into a development agreement (the “Agreement”) with CNS […]
Sustained Growth is Projected for Oil and Gas Companies in Indonesia
Palm Beach, FL – March 24, 2020 – Oil and gas production has a long history in Indonesia, with Indonesia being an international pioneer in many areas, however, the industry has not seen significant new developments for a number of years, with many existing contractors having lost interest in further exploration in Indonesia due to […]
Biotech Brief: Why Oncolytic Viruses Are Becoming A Potent Weapon Against Cancer
Palm Beach, FL –March 24, 2020 – Oncolytic viruses are becoming a new class of cancer immunotherapy weapons to combat cancer. These naturally occurring or modified viruses are a potent new weapon against cancer, according to recent reports on this growing market. The reports actually reveal that: “… since the late 1800s, doctors have observed […]
Oncolytics Biotech® Announces Favorable AWARE-1 Safety Update
Study continues enrollment in patients receiving Tecentriq combination Clinical data to be presented at ESMO Breast in May San Diego, CA and Calgary, AB – March 24, 2020 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced a favourable assessment from the Safety Committee […]
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Palm Beach, FL – March 23, 2020 – In the months since the global public health crisis rose from a regional crisis to a global threat, drug makers large and small have scrambled to advance their best ideas for thwarting a pandemic. The crisis has catalyzed the development of novel vaccines across the biotech industry, […]
CNS Pharmaceuticals Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates for a Range of Viruses including Coronavirus for International Markets
Houston, TX – March 23, 2020 – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company primarily specializing in the development of novel treatments for cancers of the brain and central nervous system, announces it has entered into an agreement with WPD Pharmaceuticals Inc. (CSE: WBIO) for the development of several preclinical […]
